Our May Investor Connect virtual program features Luma Group, an early-stage venture capital fund that invests in therapeutic, diagnostic, and medical device companies from Seed through Series B. Luma has a technology-first investment thesis and invests primarily in platform companies developing first-in-class or best-in-class assets. They partner with visionary founders to build transformative companies, not just by investing capital, but by sharing deep industry expertise, strategic guidance, and a strong network to help them grow and scale. Learn more and apply here: https://lnkd.in/eKqxPgiC Together with Browne Consulting and Silicon Valley Bank
LaunchBio Inc.
生物技术
San Diego，CA 3,999 位关注者
A nonprofit organization that delivers programming designed to connect life science entrepreneurs and investors.
关于我们
LaunchBio is a nonprofit organization formed to identify, counsel, and support high-growth, high-impact life science and biotechnology companies through regional and national collaboration with ecosystem partners. LaunchBio’s mission is to build an ecosystem of innovation for the benefit of human health and well-being.
- 网站
-
http://www.launchbio.org
LaunchBio Inc.的外部链接
- 所属行业
- 生物技术
- 规模
- 11-50 人
- 总部
- San Diego，CA
- 类型
- 非营利机构
- 创立
- 2017
- 领域
- Biotechnology和Science
地点
LaunchBio Inc.员工
动态
-
Welcome, Natalia! We are pleased to introduce LaunchBio's summer intern, Natalia Relic, to our community. Natalia is based out of San Diego and is currently pursuing a Master’s in Biotechnology Enterprise and Entrepreneurship through Johns Hopkins University online program. She holds a B.S. in Global Health from UC San Diego. She first got connected with LaunchBio when she attended our February Invest in Cures forum.
-
-
Join us on April 25 for a Lunch & Learn catered by Board & Brew to learn about the Curebound Cancer Challenge and LaunchBio’s Founders Team. Formerly called Padres Pedal the Cause, this is Curebound’s 12th annual bike/spin/run/walk fundraiser for cancer research, for which 100% of donations go directly to research institutes right here in San Diego. Space is limited; register to join us: https://lnkd.in/ezhUDMnu
-
-
Join us on April 24 for our annual Compensation Confidential webinar, where Jody K. Thelander, Founder & CEO of J. Thelander Consulting, will share real-time data on base salaries, actual and target bonuses, founder and non-founder equity and more. Gain practical insights to help structure competitive packages and retain top talent. Learn more and register here: https://lnkd.in/exY3c7G5
-
-
Continuing with the success of last year’s NextGen VC Forum, we’re back on the West Coast on Tuesday, May 6, with three new panel discussions: Biotech, AI, and the Law: Today’s Legal Considerations, Biotech Companies and Investors Facing a Growing National Security Regulatory Thicket, and From US to China: The Legal Playbook for Biotech Spinouts. This is the premier event for venture capital professionals to deepen their knowledge of the life science and biotech sectors while building meaningful connections across the industry. Space is limited; learn more and request an invite here: https://lnkd.in/exQnbFdg In partnership with Wilson Sonsini Goodrich & Rosati
-
-
More great insights on gene therapy! Thanks to Fondation Ipsen for sharing Dr Stephanie Cherqui's expertise, which was captured at our February Invest in Cures forum!
🎥 What is Gene Therapy? For people living with rare diseases, traditional medicine isn’t always enough. But gene therapy offers new hope by addressing the root cause of these conditions. In this video, Dr. Stephanie Cherqui explains how gene therapy works and why it could transform treatment for rare genetic diseases. 👉 Watch now to learn more about this groundbreaking approach: https://lnkd.in/eVFbT_Pi #GeneTherapy #RareDisease #Biotech #Innovation This video was filmed at the #InvestinCures event by LaunchBio Inc.
-
🎤 NextGen VC Podcast alert! 🎤 Join hosts Michael Hostetler and Jennifer Fang of Wilson Sonsini Goodrich & Rosati as they are joined by Felix Breyer, PhD of J.P. Morgan Life Sciences Private Capital. Felix, with a background as a molecular and cellular biologist, dives deep into the critical role of private capital in life sciences and biotech. He shares his journey from academia to venture capital, emphasizes the importance of mentorship, and provides an insider’s perspective on the evolving landscape of biotech investing. Tune in to explore key trends, challenges, and opportunities in the biotech sector, and gain valuable insights for aspiring venture capitalists. Listen here: https://lnkd.in/ey9V_RHK #VentureCapital #HealthcareInnovation #Podcast #LifeSciences #WSLifeSci #BuildingBetterBiotechs
-
-
We're pleased to announce the launch of Investor Connect RARE! We'll be joined by the Cystic Fibrosis Foundation on June 11. We'll be sharing the schdule featuring other rare disease foundations in the coming weeks. Learn more and apply today: https://lnkd.in/gJ5qWEgW
-
-
Don't miss these great insights from Lydia McClure (Research Bridge Partners). Thanks to Fondation Ipsen for putting this together at Invest in Cures!
💡 How does disruption fuel breakthrough science? 🎙️ At LaunchBio Inc.’s Invest in Cures Event, Dr. Lydia McClure, CEO of Research Bridge Partners, shared how disruption shapes investment decisions in scientific innovation: “Finding the points of nexus where innovation happens across disciplines is crucial.” 🎥 Learn more about how cutting-edge science becomes life-saving therapies: https://lnkd.in/eW4QYWMG #Innovation #Disruption #Biotech #InvestInCures #LaunchBio #RareDisease #RareDiseaseTreatment
-
Our next virtual Investor Connect is March 27 with Lilly Ventures. They deploy customized engagement models to co-invest with world-class syndicate partners and offer counsel and connections within its global network with the goal of maximizing a company’s scientific impact. Learn more and apply today: https://lnkd.in/ekZF3n36 Together with Browne Consulting and Silicon Valley Bank
-